BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 23900351)

  • 41. MiR-1 targets PIK3CA and inhibits tumorigenic properties of A549 cells.
    Yu QQ; Wu H; Huang X; Shen H; Shu YQ; Zhang B; Xiang CC; Yu SM; Guo RH; Chen L
    Biomed Pharmacother; 2014 Mar; 68(2):155-61. PubMed ID: 24486107
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MicroRNA-107 inhibits proliferation of prostate cancer cells by targeting cyclin E1.
    Zhang X; Jin K; Luo JD; Liu B; Xie LP
    Neoplasma; 2019 Sep; 66(5):704-716. PubMed ID: 31129966
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-124 inhibits cellular proliferation and invasion by targeting Ets-1 in breast cancer.
    Li W; Zang W; Liu P; Wang Y; Du Y; Chen X; Deng M; Sun W; Wang L; Zhao G; Zhai B
    Tumour Biol; 2014 Nov; 35(11):10897-904. PubMed ID: 25085587
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vector-based miR-15a/16-1 plasmid inhibits colon cancer growth in vivo.
    Dai L; Wang W; Zhang S; Jiang Q; Wang R; Dai L; Cheng L; Yang Y; Wei YQ; Deng HX
    Cell Biol Int; 2012 Aug; 36(8):765-70. PubMed ID: 22574716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. microRNA-25 Inhibits Cell Apoptosis of Human Gastric Adenocarcinoma Cell Line AGS via Regulating CCNE1 and MYC.
    Zhang Y; Peng Z; Zhao Y; Chen L
    Med Sci Monit; 2016 Apr; 22():1415-20. PubMed ID: 27120728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-7 inhibits proliferation, migration and invasion of thyroid papillary cancer cells via targeting CKS2.
    Hua K; Jin J; Zhang H; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 Oct; 49(4):1531-1540. PubMed ID: 27633373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-503 suppresses proliferation and cell-cycle progression of endometrioid endometrial cancer by negatively regulating cyclin D1.
    Xu YY; Wu HJ; Ma HD; Xu LP; Huo Y; Yin LR
    FEBS J; 2013 Aug; 280(16):3768-79. PubMed ID: 23731275
    [TBL] [Abstract][Full Text] [Related]  

  • 48. E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter.
    Chu J; Zhu Y; Liu Y; Sun L; Lv X; Wu Y; Hu P; Su F; Gong C; Song E; Liu B; Liu Q
    Oncotarget; 2015 Oct; 6(31):31944-57. PubMed ID: 26397135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.
    Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L
    Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883
    [TBL] [Abstract][Full Text] [Related]  

  • 50. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metformin targets a YAP1-TEAD4 complex via AMPKα to regulate CCNE1/2 in bladder cancer cells.
    Wu Y; Zheng Q; Li Y; Wang G; Gao S; Zhang X; Yan X; Zhang X; Xie J; Wang Y; Sun X; Meng X; Yin B; Wang B
    J Exp Clin Cancer Res; 2019 Aug; 38(1):376. PubMed ID: 31455378
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-183/-96/-182 cluster is up-regulated in most breast cancers and increases cell proliferation and migration.
    Li P; Sheng C; Huang L; Zhang H; Huang L; Cheng Z; Zhu Q
    Breast Cancer Res; 2014 Nov; 16(6):473. PubMed ID: 25394902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MiR-153 inhibits epithelial-mesenchymal transition by targeting metadherin in human breast cancer.
    Li W; Zhai L; Zhao C; Lv S
    Breast Cancer Res Treat; 2015 Apr; 150(3):501-9. PubMed ID: 25794773
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tumour-suppressive microRNA-424-5p directly targets CCNE1 as potential prognostic markers in epithelial ovarian cancer.
    Liu J; Gu Z; Tang Y; Hao J; Zhang C; Yang X
    Cell Cycle; 2018; 17(3):309-318. PubMed ID: 29228869
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA-874-mediated inhibition of the major G
    Ghosh T; Varshney A; Kumar P; Kaur M; Kumar V; Shekhar R; Devi R; Priyanka P; Khan MM; Saxena S
    J Biol Chem; 2017 Dec; 292(52):21264-21281. PubMed ID: 29109143
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer.
    Chiyomaru T; Enokida H; Kawakami K; Tatarano S; Uchida Y; Kawahara K; Nishiyama K; Seki N; Nakagawa M
    Urol Oncol; 2012; 30(4):434-43. PubMed ID: 20843712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MiR-492 contributes to cell proliferation and cell cycle of human breast cancer cells by suppressing SOX7 expression.
    Shen F; Cai WS; Feng Z; Li JL; Chen JW; Cao J; Xu B
    Tumour Biol; 2015 Mar; 36(3):1913-21. PubMed ID: 25407488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. p53-induced miR-15a/16-1 and AP4 form a double-negative feedback loop to regulate epithelial-mesenchymal transition and metastasis in colorectal cancer.
    Shi L; Jackstadt R; Siemens H; Li H; Kirchner T; Hermeking H
    Cancer Res; 2014 Jan; 74(2):532-42. PubMed ID: 24285725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.